<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=The_Leading_Add_Ons_Designed_for_Bosutinib</id>
		<title>The Leading Add Ons Designed for Bosutinib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=The_Leading_Add_Ons_Designed_for_Bosutinib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Leading_Add_Ons_Designed_for_Bosutinib&amp;action=history"/>
		<updated>2026-05-05T15:09:57Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=The_Leading_Add_Ons_Designed_for_Bosutinib&amp;diff=179639&amp;oldid=prev</id>
		<title>Burst58alto: Створена сторінка: The damage threshold and the E and F ratios for testing conducted at 60?mm/s were compared with the data generated using a low-velocity tendon excursion of 2?mm...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=The_Leading_Add_Ons_Designed_for_Bosutinib&amp;diff=179639&amp;oldid=prev"/>
				<updated>2017-05-23T07:03:58Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: The damage threshold and the E and F ratios for testing conducted at 60?mm/s were compared with the data generated using a low-velocity tendon excursion of 2?mm...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The damage threshold and the E and F ratios for testing conducted at 60?mm/s were compared with the data generated using a low-velocity tendon excursion of 2?mm/s, previously published.[15] Results were analyzed using a repeated measure ANOVA to examine differences among the ratios of each parameter for each excursion magnitude. The defined damage threshold was compared with that of the low-velocity tendon excursion data.[15] In addition, a one-way ANOVA was used to compare high-velocity tendon excursion data with low-velocity tendon excursion data. p Values ��0.05 were considered significant. Detailed results are displayed in Table 1. No significant difference was found when comparing E2/E1 ratio to E3/E1 ratio or when comparing F2/F1 ratio to F3/F1 ratio (p?��?0.066) for any excursion level. The lack of difference between the different ratios of the same excursion [http://www.selleckchem.com/products/byl719.html Alpelisib] levels confirmed that substantially all the viscoelastic recovery had taken place.[15] The E2/E1 ratios at 60%, 90%, and 120% of the physiological excursion were significantly lower than that at 40% (p?��?0.023). [http://www.selleckchem.com/products/Bosutinib.html Bosutinib purchase] The E2/E1 ratios at 90% and 120% were also significantly lower than that at 60% (p?��?0.009). There was no significant difference in E2/E1 ratios between 90% and 120% of the physiological excursion (Fig. 4). The F2�CF1 ratios at 60%, 90%, and 120% were significantly lower than that a 40% (p?��?0.009). The F2�CF1 ratios at 90% and 120% were also significantly lower compared to that at 60% (p?��?0.002). There was no significant [https://en.wikipedia.org/wiki/Dabigatran Dabigatran] difference between ratio F2�CF1 at 90% and 120%. When comparing the high-velocity excursion results with those at low-velocity,[15] resistance energy was observed to be substantially greater at all excursions (p?��?0.031; Fig. 5). Significantly more force was needed for high-velocity excursion solely at 40% and 60% of the physiological excursion, as well as at 90% when removing one outlier (p?&lt;/div&gt;</summary>
		<author><name>Burst58alto</name></author>	</entry>

	</feed>